Aminopyrimidine derivatives and their medical use

Details for Australian Patent Application No. 2004228352 (hide)

Owner Novartis AG

Inventors Janser, Philipp; Walchli, Rudolf; Denholm, Alastair; Revesz, Laszlo; Hersperger, Rene; Bollbuck, Birgit; Schlapbach, Achim; Eder, Jorg

Agent Davies Collison Cave

Pub. Number AU-B-2004228352

PCT Pub. Number WO2004/089913

Priority 0308466.2 11.04.03 GB

Filing date 8 April 2004

Wipo publication date 21 October 2004

Acceptance publication date 6 March 2008

International Classifications

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/089913 Priority application(s): WO2004/089913

6 March 2008 Application Accepted

  Published as AU-B-2004228352

3 July 2008 Standard Patent Sealed

4 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004228354-N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine D3 receptor

2004228342-Method and system for management and configuration of remote agents